Table 4 Univariate analysis for clinical parameters associated with the occurrence of relapse and/or metastasis
Characteristic | Pelvic relapse and/or metastases | P value | |
|---|---|---|---|
Yes (n = 31) | No (n = 120) | ||
Age | 47.97 ± 10.317 | 52.11 ± 11.54 | 0.071 |
Menopausal status | 0.043 | ||
Premenopausal | 20 (27.4 %) | 53 (72.6 %) | |
Postmenopausal | 11 (14.1 %) | 67 (85.9 %) | |
Age of marriage (years) | 18.57 ± 2.84 | 17.79 ± 3.86 | 0.393 |
Age of first pregnancy (years) | 21.86 ± 4.26 | 19.97 ± 4.97 | 0.124 |
Parity | 3.79 ± 2.04 | 5.19 ± 2.65 | 0.010 |
Tumor size (cm) | 5.19 ± 2.01 | 4.62 ± 1.50 | 0.168 |
Parametrial invasion | 21 (22.1 %) | 74 (77.9 %) | 0.596 |
Histological type | 0.281 | ||
Squamous cell carcinoma | 24 (18.8 %) | 104 (81.2 %) | |
Adenocarcinoma | 6 (35.3 %) | 11 (64.7 %) | |
Pelvic adenopathy | 4 (23.5 %) | 13 (76.5 %) | 0.658 |
Hemoglobin (g/dl) | 11.62 ± 1.61 | 11.97 ± 1.88 | 0.448 |
FIGO stage | 0.052 | ||
I, IIA and proximal IIB | 8 (12.3 %) | 57 (87.7 %) | |
Distal IIB, III and IV | 16 (25.8 %) | 46 (74.2 %) | |
Therapeutic Modalities | 0.151 | ||
Concomitant radio-chemotherapy | 18 (27.3 %) | 48 (72.7 %) | |
Radio-surgery | 10 (14.7 %) | 58 (85.3 %) | |